United States Patent and Trademark Office OG Notices: 18 June 2002
Date Type of Proceeding Issued Case (1) or App'n No. Party/Parties 5-9 OPP 111,332 King Bio Pharmaceuticals, Inc. v. King Pharmaceuticals, Inc. 5-9 EX 75/931,500 Wyndham IP Corp. Opposer's/ Applicant's/ Petitioner's Respondent's TTAB Mark and Mark and Issue Decision Goods/Services Goods/Services 2(d); Opposition "KING affirmative Sustained PHARMACEUTICALS," defense "KING BIO "KING" asserting PHARMACEU- (and design), opposer's TICALS" and mark is [non- "KING primarily prescription PHARMACEUTICALS" merely a homeopathic (and design) surname and remedies] [all three marks not distinc- for pharmaceuti- tive as a cals for human and trademark for veterinary use, opposer's namely, morphine, goods codeine, and related inject- ables; cough syrup, antihistamines, decongestants, dermatological preparations, and vitamins] Section 6 Refusal "WYNDHAM WIRED" disclaimer Affirmed [hotel services, requirement namely, offering (of the high-technology word WIRED) room furnishings upgrades to business travelers] Mark and Citable as Goods Cited by Precedent Examining Atty. of TTAB No No (1)EX=EX PARTE APPEAL; OPP=OPPOSITION; CANC=CANCELLATION; CU=CONCURRENT USE; (SJ)=SUMMARY JUDGMENT; (R)=REQ. FOR RECONSIDERATION; (MD)=MOTION TO DISMISS; (MR)=MOTION TO REOPEN